Gentian Diagnostics AS Stock Oslo Bors
Equities
NO0010748866
Medical Equipment, Supplies & Distribution
Sales 2024 * | 174M 16.04M 21.77M | Sales 2025 * | 226M 20.77M 28.19M | Capitalization | 595M 54.74M 74.29M |
---|---|---|---|---|---|
Net income 2024 * | 7M 644K 874K | Net income 2025 * | 13M 1.2M 1.62M | EV / Sales 2024 * | 3.05 x |
Net cash position 2024 * | 63M 5.79M 7.86M | Net cash position 2025 * | 65M 5.98M 8.11M | EV / Sales 2025 * | 2.35 x |
P/E ratio 2024 * |
77.6
x | P/E ratio 2025 * |
44
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.85% |
Latest transcript on Gentian Diagnostics AS
Managers | Title | Age | Since |
---|---|---|---|
Hilja Ibert
CEO | Chief Executive Officer | - | 18-07-15 |
Njaal Kind
DFI | Director of Finance/CFO | 52 | 18-01-01 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Settevik
CHM | Chairman | 64 | - |
Fredrik Thoresen
BRD | Director/Board Member | 44 | - |
Director/Board Member | 60 | - |
1st Jan change | Capi. | |
---|---|---|
-1.89% | 12.56B | |
-9.59% | 7.68B | |
-1.31% | 5.29B | |
+21.82% | 5.18B | |
+0.02% | 4.57B | |
-50.89% | 3.29B | |
+6.42% | 2.6B | |
-10.02% | 2.2B | |
-8.29% | 1.79B |